| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/HR.2010.233 |
| P698 | PubMed publication ID | 21124326 |
| P2093 | author name string | Kazuo Kitamura | |
| Tanenao Eto | |||
| Naoto Yokota | |||
| Johji Kato | |||
| Noboru Tamaki | |||
| Toshihiro Kita | |||
| Takao Ayabe | |||
| Sumito Kariya | |||
| P2860 | cites work | Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack | Q28190600 |
| Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy | Q29615215 | ||
| Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) | Q29618529 | ||
| Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group | Q29619460 | ||
| Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A | Q33989952 | ||
| Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group | Q34025761 | ||
| Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol | Q34522261 | ||
| Treatment of hypertension in patients 80 years of age or older | Q34766135 | ||
| One-year effectiveness and safety of open-label losartan/hydrochlorothiazide combination therapy in Japanese patients with hypertension uncontrolled with ARBs or ACE inhibitors | Q42645764 | ||
| Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT) | Q42665970 | ||
| Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial | Q43156210 | ||
| Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia | Q44260654 | ||
| Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. | Q44588871 | ||
| Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients. | Q46099840 | ||
| Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients | Q46217490 | ||
| Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study | Q46691578 | ||
| Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. | Q46825699 | ||
| Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure | Q48425209 | ||
| 2007 Guidelines for the Management of Arterial Hypertension | Q56970780 | ||
| Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004) | Q79968445 | ||
| Evidence-based practice guideline for the treatment of CKD | Q84978295 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 331-335 | |
| P577 | publication date | 2010-12-02 | |
| P1433 | published in | Hypertension Research | Q15762136 |
| P1476 | title | Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension | |
| P478 | volume | 34 |
| Q37907100 | Hydrochlorothiazide versus calcium channel blockers: what is the best add-on to a renin-angiotensin system blocker for treating hypertension in patients with renal disease? |
| Q38156340 | Olmesartan in the treatment of hypertension in elderly patients: a review of the primary evidence |
| Q61654091 | Olmesartán con diuréticos o con antagonistas del calcio: ¿a qué perfil de paciente hipertenso? |
| Q37116841 | Renoprotective effects of renin-angiotensin system inhibitor combined with calcium channel blocker or diuretic in hypertensive patients: A PRISMA-compliant meta-analysis |
| Q57463189 | The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis |
| Q90212013 | Thiazide Diuretic-Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials |
Search more.